Insider trades
Jula Inrig, Chief Officer of Travere Therapeutics TVTX, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/22.
Jula Inrig
Chief Medical Officer
- Company
- Travere Therapeutics TVTX
- First filing
- 23/01/06
- Trades
- 45 trades
- Buys / sales
- 0 / 24
- 12-month net buying
- −$2.4M
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TVTX | Open-market sale10b5-1 plan | 05/04–05/06 | 05/06 | 22,485 sh3 trades | $45.15avg. | $1,015,085.55 | −16.6% |
TVTX | Open-market sale10b5-1 plan | 04/14–04/15 | 04/15 | 8,233 sh2 trades | $42.01avg. | $345,901.93 | −6.9% |
TVTX | Open-market sale10b5-1 plan | 02/04 | 02/05 | 1,779 sh2 trades | $32.21avg. | $57,295.37 | −1.7% |
| Open-market sale | 02/03 | 02/03 | 6,956 sh | $32.12 | $223,426.72 | −6.1% | |
TVTX | Open-market sale10b5-1 plan | 01/05–01/06 | 01/07 | 2,476 sh2 trades | $39.74avg. | $98,404.33 | −2.8% |
| Open-market sale10b5-1 plan | 25/12/24 | 25/12/29 | 15,000 sh | $42.00 | $630,000 | −14.5% | |
| Open-market sale10b5-1 plan | 25/07/01 | 25/07/02 | 815 sh | $14.65 | $11,939.75 | −0.9% | |
| Open-market sale | 25/02/12 | 25/02/12 | 2,568 sh | $23.53 | $60,425.04 | −2.8% | |
TVTX | Open-market sale10b5-1 plan | 25/02/03–25/02/04 | 25/02/04 | 5,273 sh2 trades | $20.12avg. | $106,082.1 | −5.9% |
TVTX | Open-market sale10b5-1 plan | 25/01/03–25/01/06 | 25/01/06 | 2,506 sh2 trades | $19.04avg. | $47,715 | −4.0% |
| Open-market sale10b5-1 plan | 24/09/10 | 24/09/10 | 684 sh | $12.98 | $8,878.32 | −1.1% | |
| Open-market sale | 24/09/09 | 24/09/09 | 2,191 sh | $11.52 | $25,240.32 | −3.4% | |
| Open-market sale | 24/02/01 | 24/02/02 | 2,174 sh | $8.53 | $18,544.22 | −3.6% | |
TVTX | Open-market sale | 24/01/03–24/01/04 | 24/01/05 | 2,509 sh2 trades | $9.43avg. | $23,648.92 | −6.6% |
TVTX | Open-market sale | 23/01/04–23/01/05 | 23/01/06 | 2,493 sh2 trades | $20.75avg. | $51,729.75 | −12.5% |